As of 2026-10-13, the EV/EBITDA ratio of Erytech Pharma SA (ERYP.PA) is 0.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ERYP.PA's latest enterprise value is -11.85 mil EUR. ERYP.PA's TTM EBITDA according to its financial statements is -23.57 mil EUR. Dividing these 2 quantities gives us the above ERYP.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.7x - 8.9x | 7.8x |
| Forward P/E multiples | 10.0x - 12.1x | 11.0x |
| Fair Price | (7.85) - (6.89) | (7.35) |
| Upside | -1674.1% - -1480.2% | -1572.8% |
| Date | EV/EBITDA |